Work

Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis

Year: 2008

Type: article

Source: Nature Biotechnology

DOI: 10.1038/nbt.1490

Authors: Shirit Einav, Doron Gerber, Paul D Bryson, Ella H Sklan, Menashe Elazar, Sebastian J Maerkl, Jeffrey S Glenn, Stephen R Quake

Institutions: Stanford Medicine, Stanford University, Howard Hughes Medical Institute, École Polytechnique Fédérale de Lausanne

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: American Liver Foundation, National Institutes of Health, National Human Genome Research Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: NIH Director's Pioneer Award (RMI), Ultrasensitive Nanofluidic Devices for Genomic Analysis, Novel Antiviral Targets in Hepatitis C virus NS4B

OpenAlex ID: W2113749416

FWCI: 14.77

Cites: 37

Cited by: 244

Related to: 10